Heart Failure Clinics

Article	Citations
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure	57
Unusual Forms of Pulmonary Hypertension	36
Tafamidis in the Treatment of ATTR-related Cardiomyopathy	31
Treatment of Advanced Heart Failure—Focus on Transplantation and Durable Mechanical Circulatory Support	27
Changing Landscape of Heart Failure Imaging	26
Contents	26
Forthcoming Issues	23
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia	22
Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging	21
When all Else Fails, Try This	20
Understanding Myocardial Metabolism in the Context of Cardio-Oncology	20
Therapy-Related Clonal Hematopoiesis	19
Preload Reduction Therapies in Heart Failure	19
Mitral Regurgitation	18
Rare Cardiovascular Diseases: From Genetics to Personalized Medicine	18
Genetics of High-Altitude Pulmonary Edema	18
Heart Failure in Adults with Congenital Heart Disease: The Time to Act is Now	17
Contributors	16
Contributors	16
Arrhythmias in Adult Congenital Heart Disease Heart Failure	16
Contributors	15
Specific Therapy in Transthyretin Amyloid Cardiomyopathy	14
Emerging Roles for Artificial Intelligence in Heart Failure Imaging	13
Copyright	13
Special Considerations for Mechanical Circulatory Support or Device Therapy in Adult Congenital Heart Disease Heart Failure	12

Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure	12
Heart Failure Clinics	12
Myocardial Dysfunction in Patients with Cancer	12
Coronary Angiography in the Evaluation of Systolic Heart Failure	11
Redefining Left Ventricular Systolic Dysfunction in Hypertrophic Cardiomyopathy	11
Arrythmia-Mediated Valvular Heart Disease	11
Advanced Heart Failure in a Special Population	11
What Is New in Risk Assessment in Nuclear Cardiology?	11
Cardiac Amyloidosis	10
Guide to Temporary Mechanical Support in Cardiogenic Shock	10
Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging	10
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis	10
Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population	10
Contributors	10
Noncoding RNAs in Pulmonary Arterial Hypertension	9
Obtaining a Coronary Artery Calcium Score with Myocardial Perfusion Imaging	9
Contents	9
Cardiac Contractility Modulation	9
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis	9
SGLT2 Inhibitors in Heart Failure	9
Application of 3D Printing Technology in Heart Failure	9
The Role of Multimodality Imaging in the Evaluation of Heart Failure and Surgical Transplant Planning of Patients with Adult Congenital Heart Disease	9
Echocardiography in Advanced Heart Failure for Diagnosis, Management, and Prognosis	8
Contents	8
Disease-modifier Drugs in Patients with Advanced Heart Failure	8
Contributors	8
SGLT2 Inhibitors in Type 2 Diabetes Mellitus	7
Copyright	7
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors	7
Preface	7
Inotropes in Patients with Advanced Heart Failure	7
Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study	7
The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes	6
Aortic Valvular Stenosis and Heart Failure	6
Copyright	6
Advanced Heart Failure in Special Population	6
Radionuclide Tracers for Myocardial Perfusion Imaging and Blood Flow Quantification	6
Advanced Heart Failure: From Pathophysiology to Clinical Management	6
Contents	6
Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy	5
Adults with Congenital Heart Disease and Transplant	5
Exercise Testing in Pulmonary Hypertension and Heart Failure	5
Remote Monitoring Devices and Heart Failure	5
The Role of Medical Therapy in Hypertrophic Cardiomyopathy	5
Vision Statement and Call to Action for Adult Congenital Heart Disease Heart Failure	5
Contributors	4
SGLT2 Inhibitors and Peripheral Vascular Events	4
Clinical Use of Biomarkers in Cardiac Amyloidosis	4
Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease	4
Contents	4

Novel Non-pharmacological Approaches to Heart Failure	4
Advances in the Therapy of Light Chain Cardiac Amyloidosis	4
Pathophysiology of Cardiac Amyloidosis	4
Clinical Practice Guidelines in Cardio-Oncology	4
The Risk of Sudden Unexpected Cardiac Death in Children	4
Risk Factors for Progression in Hypertrophic Cardiomyopathy	4
Changing Landscape of Heart Failure Imaging	3
Imaging in Hypertrophic Cardiomyopathy: Beyond Risk Stratification	3
Coronary Microvascular Dysfunction	3
Clinical Value of Positron Emission Tomography Myocardial Perfusion Imaging and Blood Flow Quantification	3
Pulmonary Hypertension in Adult Congenital Heart Disease–Related Heart Failure	3
Copyright	3
Epidemiology, Pathogenesis, and Clinical Course of Takotsubo Syndrome	3
Adult Congenital Heart Disease	3
Contributors	3
Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?	3
Contents	3
Contributors	3
Forthcoming Issues	3
Forthcoming Issues	3
Latest Updates in Heart Failure Imaging	3
Novel Approaches to Sleep Apnea in Heart Failure	2
Multimodality Imaging in the Evaluation of Hypertrophic Cardiomyopathy	2
Translational Cardio-Oncology Research to Promote Better Outcomes for One and All	2
Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension	2
Clinical and Molecular Aspects of Naxos Disease	2
Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk	2
Copyright	2
Mechanical Circulatory Support in COVID-19	2
The Heart Muscle and Valve Involvement in Marfan Syndrome, Loeys-Dietz Syndromes, and Collagenopathies	2
Contents	2
Contents	2
Heart Failure Staging and Indications for Advanced Therapies in Adults with Congenital Heart Disease	2
Forthcoming Issues	2
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination	2
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19	2
Valvular Heart Failure due to Tricuspid Regurgitation	1
Radionuclide Assessment of Sarcoidosis	1
Using Artificial Intelligence to Better Predict and Develop Biomarkers	1
Percutaneous Coronary Intervention for Heart Failure due to Coronary Artery Disease	1
Challenges in Pulmonary Hypertension	1
Left Ventricular Assist Device	1
Novel PET Applications and Radiotracers for Imaging Cardiovascular Pathophysiology	1
Multimodality Imaging in Aortic Stenosis	1
Surgical Revascularization Decisions in Ischemia and Heart Failure	1
Forthcoming Issues	1
Copyright	1
Contents	1
Congestion in Patients with Advanced Heart Failure	1
Radionuclide Imaging of Infective Endocarditis	1
SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction	1
Monitoring for Valve Decrepitude: Surveillance Echo for All at Age 60…?	1
How to Start an Invasive Cardiopulmonary Exercise Testing Program	1
Translational Research in Cardio-Oncology	1
Contributors	1
Copyright	1
Cardiac PET Imaging for Coronary Artery Disease and Heart Failure	1
Contributors	1
Nuclear Cardiology	1
Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies	1
Contributors	1
Obesity in Heart Failure with Reduced Ejection Fraction	1
Use and Prognostic Implications of Cardiac Troponin in COVID-19	1
Challenges in Pulmonary Hypertension	1
SGLT2 Inhibitors and Heart Failure with Preserved Ejection Fraction	1
Valvular Heart Disease and Heart Failure	0
Modeling Susceptibility to Cardiotoxicity in Cancer Therapy Using Human iPSC-Derived Cardiac Cells and Systems Biology	0
Contributors	0
Phenotyping the Many Faces of Hypertrophic Cardiomyopathy	0
Renoprotective Effects of SGLT2 Inhibitors	0
Artificial Intelligence and Mechanical Circulatory Support	0
Heart Failure with Reduced Ejection Fraction	0
Interatrial Shunt Devices	0
Epidemiology and Definition of Heart Failure in Adult Congenital Heart Disease	0
Copyright	0
SGLT2 Inhibitors Are Lifesavers in Heart Failure	0
Surgical Considerations in Adult Congenital Heart Disease Heart Failure	0
Contents	0
Training and Career Development in Cardio-Oncology Translational and Implementation Science	0
Advanced Heart Failure in Special Population—Pediatric Age	0

Digital Health	0
Contents	0
Racial, Ethnic, and Gender Disparities in Valvular Heart Failure Management	0
The War Against Heart Failure Hospitalizations	0
Copyright	0
Coronary Artery Disease and Heart Failure	0
Nuclear Cardiology in 2023	0
Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction	0
Contributors	0
Left Ventricular Assist Device and the Current State of the Art: HeartMate 3 at 5 Years	0
Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension	0
Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction	0
Cardiac Implantable Electronic Devices in Ischemic Cardiomyopathy	0
Contents	0
Contents	0
New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia	0
Genetics in Congenital Heart Diseases	0
Cardiopulmonary Exercise Testing, Rehabilitation, and Exercise Training in Postpulmonary Embolism	0
Copyright	0
Forthcoming Issues	0
Contents	0
Framework for Digital Health Phenotypes in Heart Failure	0
Cardiopulmonary Exercise Testing in Research	0
The Arrhythmic Phenotype in Cardiomyopathy	0
Listing Criteria for Heart Transplant	0
Forthcoming Issues	0
Evaluation of Coronary Artery Disease and Ischemia by Echocardiography	0
Forthcoming Issues	0
Copyright	0
Forthcoming Issues	0
Forthcoming Issues	0
Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity	0
Contributors	0
Utilizing Artificial Intelligence to Enhance Health Equity Among Patients with Heart Failure	0
Impact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care	0
Interventional Approaches to Augment Pharmacotherapy in Heart Failure	0
Covid-19	0
Heart Failure Preserved Ejection Fraction in Women	0
Cardiopulmonary Exercise Testing in Pulmonary Hypertension	0
Cardiovascular Involvement in mtDNA Disease	0
PET Imaging for Cardiomyopathy Challenges Simplistic Notions of Ischemia and Viability	0
Cardioprotection of High-Risk Individuals	0
Forthcoming Issues	0
Tricuspid Regurgitation and Right Heart Failure	0
Arrhythmogenic Cardiomyopathy	0
Contributors	0
Targeted Therapies for Microvascular Disease	0
Contents	0
Secondary Mitral Regurgitation and Heart Failure	0
Spontaneous Coronary Artery Dissection	0
Cardiac Amyloidosis	0
Standard Therapy in Cardiac Amyloidosis	0
The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy	0
Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events	0
Utilizing Conversational Artificial Intelligence, Voice, and Phonocardiography Analytics in Heart Failure Care	0
Palliative Care in Adult Congenital Heart Disease–Associated Advanced Heart Disease	0
Arrhythmic Stratification of Cardiac Amyloidosis	0
The Ability of Near-Infrared Spectroscopy to Identify Vulnerable Patients and Plaques: A Systematic Review and Meta-Analysis	0
How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice	0
Contents	0
Contents	0
Pregnancy and Pulmonary Hypertension	0
Failing with Cyanosis-Heart Failure in End-Stage Unrepaired or Partially Palliated Congenital Heart Disease	0
Cardiovascular Effects of COVID-19	0
Oxygen Therapy in Pulmonary Vascular Disease	0
Microscopic Examination of Clots from Percutaneous Mechanical Embolectomies in Pulmonary Embolism	0
Stress-First Myocardial Perfusion Imaging	0
Forthcoming Issues	0
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis	0
Copyright	0
The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis	0
Clinical Manifestations of 22q11.2 Deletion Syndrome	0
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis	0
Impact of Hormonal-Anabolic Deficiencies in Idiopathic Pulmonary Arterial Hypertension	0
Obesity Management for Patients with Coronary Artery Disease and Heart Failure	0
Immune Dysregulation in Ischemic Heart Disease Among Individuals with Human Immunodeficiency Virus	0
The Non-invasive Assessment of the Pulmonary Circulation-Right Ventricular Functional Unit	0
Copyright	0
Cardiac Amyloidosis	0
Hypertrophic Cardiomyopathy in RASopathies	0
Contents	0
The Economic Burden of Heart Failure with Reduced Ejection Fraction	0
SGLT-2 Inhibitors	0
Hypertrophic Cardiomyopathy in the Absence of “Hypertrophy”	0
Contributors	0
Genotype-Phenotype Correlations in ATTR Amyloidosis	0
Viability and Congestive Heart Failure	0
The Influence of Genotype on the Phenotype, Clinical Course, and Risk of Adverse Events in Children with Hypertrophic Cardiomyopathy	0
The Emerging Role of Artificial Intelligence in Valvular Heart Disease	0
Primary Mitral Regurgitation and Heart Failure	0
Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects	0
Management of COVID-19 in Patients with Pulmonary Arterial Hypertension	0
Coronary Artery Disease and Heart Failure—Continued Significant Morbidity and Mortality Highlights Need for Comprehensive Evaluation to Individualize Patient Management	0
Evaluation of Coronary Artery Disease and Ischemia by Cardiac Magnetic Resonance Imaging	0
Exercise Testing in Elite Athletes	0